TotalMarketCap

Rhythm Pharmaceuticals

RYTMNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$7.210 B

$104.00 -6.04%

Close of 6 Nov 2026

As of 6 Nov 2026, Rhythm Pharmaceuticals (RYTM) has a market capitalization of $7.21B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$189.8M

#2287 by revenue

Earnings

-$196.5K

Loss-making

Shares outstanding

69,330,906

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #41AbivaxABVX$7.35B
  2. #42Praxis Precision MedicinesPRAX$7.34B
  3. #43Rhythm PharmaceuticalsRYTM$7.21B
  4. #44Kiniksa Pharmaceuticals InternationalKNSA$6.95B
  5. #45Axsome TherapeuticsAXSM$6.80B

What if Rhythm Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $28.2T

$407,276.86

Per share 3,916× higher

Bitcoin $1.53T

$22,037.04

Per share 212× higher

Apple $5.02T

$72,345.55

Per share 696× higher

Or at a round number

$10.0B$20.0B$50.0B$100.0B

Where these numbers come from

Share counts and financials for Rhythm Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.